Unravelling the molecular mechanisms of prostate cancer evolution from genotype to phenotype
出版年份 2021 全文链接
标题
Unravelling the molecular mechanisms of prostate cancer evolution from genotype to phenotype
作者
关键词
Prostate cancer (PC), Evolution, Genotype, Phenotype
出版物
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 163, Issue -, Pages 103370
出版商
Elsevier BV
发表日期
2021-05-27
DOI
10.1016/j.critrevonc.2021.103370
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy
- (2021) Scott Wilkinson et al. EUROPEAN UROLOGY
- Resistance to second-generation androgen receptor antagonists in prostate cancer
- (2021) Keith T. Schmidt et al. Nature Reviews Urology
- Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway
- (2020) Fangzhen Cai et al. BIOSCIENCE REPORTS
- Oncogenic ERG represses PI3K signaling through down-regulation of IRS2
- (2020) Ninghui Mao et al. CANCER RESEARCH
- Magnitude of benefit of the addition of poly ADP-ribose polymerase (PARP) inhibitors to therapy for malignant tumor: A meta-analysis
- (2020) Lihu Gu et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN)
- (2020) Tamara Jamaspishvili et al. JNCI-Journal of the National Cancer Institute
- TIP5 primes prostate luminal cells for the oncogenic transformation mediated by PTEN-loss
- (2020) Karolina Pietrzak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
- (2020) Yota Yasumizu et al. Nature Communications
- A phase II trial of Abiraterone followed by randomization to addition of Dasatinib or Sunitinib in men with metastatic castration resistant prostate cancer.
- (2020) N. Spetsieris et al. Clinical Genitourinary Cancer
- Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis
- (2020) Carlo Buonerba et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives
- (2020) Gianmarco Leone et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer
- (2020) Umang Swami et al. EUROPEAN UROLOGY
- Maintenance of sexual activity following androgen deprivation in males
- (2020) Cassian J. Duthie et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications
- (2020) Chiara Pisano et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives
- (2020) Nicole Brighi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings
- (2020) Matteo Ferro et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer
- (2019) Elena Castro et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53 missense mutation is associated with increased tumor-infiltrating T-cells in primary prostate Cancer
- (2019) Harsimar B. Kaur et al. HUMAN PATHOLOGY
- Leukemia Inhibitory Factor Promotes Castration-resistant Prostate Cancer and Neuroendocrine Differentiation by Activated ZBTB46
- (2019) Yen-Nien Liu et al. CLINICAL CANCER RESEARCH
- Genomic correlates of clinical outcome in advanced prostate cancer
- (2019) Wassim Abida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- c-Src is required for hypoxia-induced metastasis-associated functions in prostate cancer cells
- (2019) Yao Dai et al. OncoTargets and Therapy
- Neuroendocrine differentiation in castration resistant prostate cancer. Nuclear medicine radiopharmaceuticals and imaging techniques: A narrative review
- (2019) Sharjeel Usmani et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions
- (2019) Roberto Iacovelli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling
- (2019) Feng Chen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostate
- (2019) Yongfeng He et al. ONCOGENE
- LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
- (2019) Jie Luo et al. Nature Communications
- The Genomic and Molecular Pathology of Prostate Cancer
- (2019) Farzana A. Faisal et al. ADVANCES IN ANATOMIC PATHOLOGY
- CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition
- (2019) Yongning Lu et al. Cell Communication and Signaling
- PARP Inhibition Suppresses GR–MYCN–CDK5–RB1–E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer
- (2019) Bo Liu et al. CLINICAL CANCER RESEARCH
- Risk of fatigue and anemia in patients with advanced cancer treated with olaparib: A meta-analysis of randomized controlled trials
- (2019) Viviane C. Ruiz-Schutz et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression
- (2019) Hui Liu et al. NEOPLASIA
- PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer
- (2019) Chao Wang et al. FASEB JOURNAL
- Integrative clinical transcriptome analysis reveals TMPRSS2‐ERG dependency of prognostic biomarkers in prostate adenocarcinoma
- (2019) Julia S. Gerke et al. INTERNATIONAL JOURNAL OF CANCER
- Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly
- (2019) Qing Shi et al. Molecular Cancer
- Wnt activator FOXB2 drives the neuroendocrine differentiation of prostate cancer
- (2019) Lavanya Moparthi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic Alteration Burden in Advanced Prostate Cancer and Therapeutic Implications
- (2019) Matthew J. Ryan et al. Frontiers in Oncology
- Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer
- (2019) Manuela Krumbholz et al. DISEASE MARKERS
- Lineage plasticity-mediated therapy resistance in prostate cancer
- (2018) Haojie Huang et al. ASIAN JOURNAL OF ANDROLOGY
- ASC-J9 ® suppresses prostate cancer cell invasion via altering the sumoylation-phosphorylation of STAT3
- (2018) WanYing Lin et al. CANCER LETTERS
- Reciprocal Network between Cancer Stem-Like Cells and Macrophages Facilitates the Progression and Androgen Deprivation Therapy Resistance of Prostate Cancer
- (2018) Hai Huang et al. CLINICAL CANCER RESEARCH
- Clinical and molecular features of treatment-related neuroendocrine prostate cancer
- (2018) Shusuke Akamatsu et al. INTERNATIONAL JOURNAL OF UROLOGY
- Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2018) Noel Clarke et al. LANCET ONCOLOGY
- The roles of the COX2/PGE2/EP axis in therapeutic resistance
- (2018) Dali Tong et al. CANCER AND METASTASIS REVIEWS
- The STAT3 inhibitor galiellalactone reduces IL6-mediated AR activity in benign and malignant prostate models
- (2018) Florian Handle et al. MOLECULAR CANCER THERAPEUTICS
- ASPM promotes prostate cancer stemness and progression by augmenting Wnt−Dvl-3−β-catenin signaling
- (2018) Vincent C. Pai et al. ONCOGENE
- Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer
- (2018) Amilcar Flores-Morales et al. CLINICAL CANCER RESEARCH
- Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer
- (2018) Anis A. Hamid et al. EUROPEAN UROLOGY
- Integrative epigenetic taxonomy of primary prostate cancer
- (2018) Suzan Stelloo et al. Nature Communications
- TMPRSS2–ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer
- (2017) Ken J Kron et al. NATURE GENETICS
- The molecular biology of prostate cancer: current understanding and clinical implications
- (2017) Jason Gandhi et al. PROSTATE CANCER AND PROSTATIC DISEASES
- SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
- (2017) Ping Mu et al. SCIENCE
- Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
- (2017) Sheng Yu Ku et al. SCIENCE
- Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT
- (2017) Qiuli Liu et al. Cell Death & Disease
- Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
- (2017) Min Zou et al. Cancer Discovery
- Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice
- (2016) Feng Sun et al. CARCINOGENESIS
- SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells
- (2016) F. Handle et al. MOLECULAR CANCER RESEARCH
- EC-70124, a Novel Glycosylated Indolocarbazole Multikinase Inhibitor, Reverts Tumorigenic and Stem Cell Properties in Prostate Cancer by Inhibiting STAT3 and NF- B
- (2016) G. Civenni et al. MOLECULAR CANCER THERAPEUTICS
- Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine
- (2016) M. J. Alvarez-Cubero et al. Molecular Diagnosis & Therapy
- High-Content Screening Identifies Src Family Kinases as Potential Regulators of AR-V7 Expression and Androgen-Independent Cell Growth
- (2016) Adam T. Szafran et al. PROSTATE
- Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting
- (2016) E S Antonarakis et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer
- (2016) Christine Henzler et al. Nature Communications
- Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures
- (2016) Indranil Chattopadhyay et al. Oncotarget
- Rapidly progressive disease in a castration-resistant prostate cancer patient after cabazitaxel discontinuation
- (2015) Giuseppe Di Lorenzo et al. ANTI-CANCER DRUGS
- Hormone naïve prostate cancer: predicting and maximizing response intervals
- (2015) JuddW Moul ASIAN JOURNAL OF ANDROLOGY
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies
- (2015) Nader Al Nakouzi et al. EUROPEAN UROLOGY
- Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition
- (2015) Chengfei Liu et al. PROSTATE
- Aggressive Variants of Castration-Resistant Prostate Cancer
- (2014) H. Beltran et al. CLINICAL CANCER RESEARCH
- The Steroid Receptor Coactivator-3 Is Required for Developing Neuroendocrine Tumor in the Mouse Prostate
- (2014) Jean Ching-Yi Tien et al. International Journal of Biological Sciences
- Differential Requirement for Src Family Tyrosine Kinases in the Initiation, Progression, and Metastasis of Prostate Cancer
- (2014) Irwin H. Gelman et al. MOLECULAR CANCER RESEARCH
- Src: Marker or Actor in Prostate Cancer Aggressiveness
- (2014) Virginie Vlaeminck-Guillem et al. Frontiers in Oncology
- Loss of Androgen Receptor Expression Promotes a Stem-like Cell Phenotype in Prostate Cancer through STAT3 Signaling
- (2013) A. Schroeder et al. CANCER RESEARCH
- Interleukin-6
- (2012) Nikki A. Delk et al. Autophagy
- Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer
- (2012) Himisha Beltran et al. JOURNAL OF CLINICAL ONCOLOGY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- LNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signaling
- (2011) Dongxia Ge et al. PROSTATE
- Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells
- (2010) Pinar Uysal-Onganer et al. Molecular Cancer
- Wnt/β-Catenin activation promotes prostate tumor progression in a mouse model
- (2010) X Yu et al. ONCOGENE
- Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis
- (2009) T Koreckij et al. BRITISH JOURNAL OF CANCER
- Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer
- (2009) Ganesh S. Palapattu et al. PROSTATE
- The Role of SPINK1 in ETS Rearrangement-Negative Prostate Cancers
- (2008) Scott A. Tomlins et al. CANCER CELL
- Targeting Src Family Kinases Inhibits Growth and Lymph Node Metastases of Prostate Cancer in an Orthotopic Nude Mouse Model
- (2008) S. I. Park et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started